What are the two transactions Albemarle is undertaking, and how much is each worth?

Albemarle Corporation has agreed to sell a 60% stake in its Ketjen Corporation business to ROCSA for $170 million and its 50% interest in the Eurecat joint venture to catalysts-producer C.O.P.S. for $490 million.

What is the strategic rationale behind Albemarle’s divestitures, and when are they expected to close?

These transactions, totaling $660 million, are part of Albemarle's strategy to streamline its portfolio and reduce debt, and are expected to close in early 2025.

Albemarle to Sell Ketjen Controlling Stake, Eurecat Stake in Deals Totaling $660M

Apr 27, 2026

Albemarle Corp agreed to sell a 60% stake in Ketjen Corporation to ROCSA and a 50% interest in Eurecat to C.O.P.S. for a total of $660 million. The deals aim to streamline its portfolio and reduce debt, closing in early 2025.

MSN

2026-04-13

Copper Prices Surge Amid EV and Grid Demand; Mining ETFs Identified

2026-04-13

Albemarle (ALB) Surges 5.1% Amid Market Volatility

2026-04-16

Albemarle soars to nearly three-year high as lithium rebound sparks momentum

2026-04-18

Cwm LLC Increases Stake in Albemarle Corporation to $24.50 Million

2026-04-22

Rothschild Downgrades Albemarle Stock Rating on Lithium Pricing Lag